Lozano L, García-Hoyo R, Egido J
Nephron. 1987;45(2):98-103. doi: 10.1159/000184087.
From the clinical point of view patients with IgA nephropathy present two main symptoms. Some patients have episodes of macroscopic hematuria, either isolated or recurrent, while others present only asymptomatic urinary abnormalities. Although these differences could be due to age-related, geographical or other unknown reasons, in this paper we studied whether patients with these two clinical manifestations differ in some IgA immunological aspects, described occasionally as abnormal in this disease. The following results were obtained: patients having a history of macroscopic hematuria episodes (n = 29) had a significant increase in the percentage of blood polymeric-IgA-producing cells (68 +/- 12%) and in the T cells with IgA Fc-receptors (T alpha cells; 14.5 +/- 3%) in relation to those having only asymptomatic urinary abnormalities (n = 13; 48 +/- 11 and 11.8 +/- 3%, respectively). However, there was no difference in the two groups of patients in relation to the serum IgA levels, percentage of IgA-bearing cells, in vitro synthesis of IgA, T-cell subpopulation and generation of Con A-IgA suppressor cells. Since these patients did not differ in the age of the apparent onset of the disease, in age at the moment of the study or in the activity of the disease determined by hematuria, our results afford an immunological support suggesting the existence of two subgroups of patients with IgA nephropathy.
从临床角度来看,IgA肾病患者有两种主要症状。一些患者有肉眼血尿发作,可为孤立性或复发性,而另一些患者仅表现为无症状性尿液异常。尽管这些差异可能归因于年龄、地域或其他未知原因,但在本文中,我们研究了具有这两种临床表现的患者在某些IgA免疫学方面是否存在差异,这些方面在该疾病中偶尔被描述为异常。获得了以下结果:有肉眼血尿发作史的患者(n = 29)与仅有无症状性尿液异常的患者(n = 13)相比,产生血液多聚IgA的细胞百分比(68±12%)和具有IgA Fc受体的T细胞(Tα细胞;14.5±3%)显著增加(分别为48±11和11.8±3%)。然而,两组患者在血清IgA水平、携带IgA细胞的百分比、IgA的体外合成、T细胞亚群以及Con A-IgA抑制细胞的产生方面没有差异。由于这些患者在疾病明显发作的年龄、研究时的年龄或由血尿确定的疾病活动度方面没有差异,我们的结果提供了免疫学支持,提示存在IgA肾病患者的两个亚组。